Page 113 - Revista Portuguesa - SPORL - Vol 60. Nº4

Referências bibliográficas 14- Sassler AM, Esclamado RM, Wolf GT. Surgery after organ
1-Marur S, Forastiere AA. Head and neck squamous cell preservation therapy. Analysis of wound complications.
carcinoma: update on epidemiology, diagnosis, and Arch Otolaryngol Head Neck Surg. 1995 Feb;121(2):162-5.
treatment. Mayo Clin Proc. 2016 Mar;91(3):386-96. doi: doi: 10.1001/archotol.1995.01890020024006
10.1016/j.mayocp.2015.12.017. 15-Virtaniemi JA, Kumpulainen EJ, Hirvikoski PP,
2-Sturgis EM, Cinciripini PM. Trends in head and neck Johansson RT, Kosma VM. The incidence and
cancer incidence in relation to smoking prevalence: an etiology of postlaryngectomy pharyngocutaneous
emerging epidemic of human papillomavirus-associated fistulae. Head Neck. 2001; 23:29-33. doi:
cancers? Cancer. 2007 Oct 1;110(7):1429-35. doi: 10.1002/ 10.1002/1097-0347(200101)23:1<29::AID-HED5>3.0.CO;2-P
cncr.22963. 16- Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI,
3-Omura G, Saito Y, Ando M, Kobayashi K, Ebihara Y, Nguyen-Tân PF. et al. Human papillomavirus and survival
Yamasoba T. et al. Salvage surgery for local residual of patients with oropharyngeal cancer. N Engl J Med. 2010
or recurrent pharyngeal cancer after radiotherapy or Jul 1;363(1):24-35. doi: 10.1056/NEJMoa0912217.
chemoradiotherapy. Laryngoscope. 2014 Sep;124(9):2075-
80. doi: 10.1002/lary.24695
4-Hay A, Simo R, Hall G, Tharavai S, Oakley R, Fry A. et
al. Outcomes of salvage surgery for the oropharynx and
larynx: a contemporary experience in a UK Cancer Centre.
Eur Arch Otorhinolaryngol. 2019 Apr;276(4):1153-1159. doi:
10.1007/s00405-019-05295-x.
5-Chen AY, Schrag N, Hao Y, Stewart A, Ward E. Changes
in treatment of advanced oropharyngeal cancer, 1985-
2001. Laryngoscope. 2007 Jan;117(1):16-21. doi: 10.1097/01.
mlg.0000240182.61922.31.
6-Chen AY, Zhu J, Fedewa S. Temporal trends in
oropharyngeal cancer treatment and survival: 1998-2009.
Laryngoscope. 2014 Jan;124(1):131-8. doi: 10.1002/lary.24296.
7-Bird T, De Felice F, Michaelidou A, Thavaraj S, Jeannon
JP, Lyons A. et al. Outcomes of intensity-modulated
radiotherapy as primary treatment for oropharyngeal
squamous cell carcinoma – a European single institution
analysis. Clin Otolaryngol. 2017 Feb;42(1):115-122. doi: 10.1111/
coa.12674.
8-Zafereo ME, Hanasono MM, Rosenthal DI, Sturgis EM,
Lewin JS, Roberts DB. et al. The role of salvage surgery
in patients with recurrent squamous cell carcinoma of
the oropharynx. Cancer. 2009 Dec 15;115(24):5723-33. doi:
10.1002/cncr.24595.
9- Embring A, Onjukka E, Mercke C, Lax I, Berglund A,
Bornedal S. et al. Re-irradiation for head and neck cancer:
cumulative dose to organs at risk and late side effects.
Cancers (Basel). 2021 Jun 25;13(13):3173. doi: 10.3390/
cancers13133173.
10- Goodwin WJ Jr. Salvage surgery for patients with
recurrent squamous cell carcinoma of the upper
aerodigestive tract: when do the ends justify the means?
Laryngoscope. 2000 Mar;110(3 Pt 2 Suppl 93):1-18. doi:
10.1097/00005537-200003001-00001.
11- Culié D, Lisan Q, Leroy C, Modesto A, Schiappa R,
Chamorey E. et al. Oropharyngeal cancer: first relapse
description and prognostic factor salvage treatment
according to p16 status, a GETTEC multicentric study. Eur J
Cancer. 2021 Jan;143:168-177. doi: 10.1016/j.ejca.2020.10.034.
12- Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel
DM, Bruce JY. et al. NCCN Clinical Practice Guidelines in
Oncology – Head and Neck Cancers. NCCN Guidelines.
2021; ST-4-7.
13- Righini CA, Nadour K, Faure C, Rtail R, Morel N,
Beneyton V. et al. Salvage surgery after radiotherapy for
oropharyngeal cancer. Treatment complications and
oncological results. Eur Ann Otorhinolaryngol Head Neck
Dis. 2012 Feb;129(1):11-6. doi: 10.1016/j.anorl.2011.06.002.

Volume 60 . Nº4 . Dezembro 2022 385